Feasibility and response to nedaplatin monotherapy in older patients with ovarian cancer.
Hiroyuki YoshidaDaisuke ShintaniAiko OgasawaraKeiichi FujiwaraPublished in: Archives of gynecology and obstetrics (2017)
Although NDP is a useful therapeutic option for OC, careful consideration of the adverse effect should be given for patients 70 years and older.